Company profile · Biotech & medical
Taigen Biopharmaceuticals Holdings
太景醫藥研發控股股份有限公司 · 4157
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Taigen Biopharmaceuticals Holdings is a pharmaceutical research and development company focused on the development of anti-infective drugs.[1]
The company engages in new drug research and development.[1]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$5m | +60.2% | +66.6% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | −NT$5m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED |
|---|---|
| Chinese name | 太景醫藥研發控股股份有限公司 |
| Stock code | 4157 (TPEx) |
| Industry | Biotech & medical |
| Founded | 15 Sep 2005 |
| Listed | 17 Jan 2014 |
| Paid-in capital | NT$21m |
| Chairman | 黃國龍 |
| President | 張俐雯 |
| Headquarters | Box 309, Ugland House Grand Cayman, KY1-1104, Cayman Islands |
| Website | http://www.taigenbiotech.com/ |
| Official business description | 新藥研發 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 太景醫藥研發控股股份有限公司 · mops · retrieved 04 Nov 2026
The Week in Taiwan Companies · free, every Friday
Using it at work? Join the team-plan waiting list
Using it at work? Join the team-plan waiting list